In a retrospective Japanese study, elevated serum KL-6 levels were not associated with prognosis in patients with lung cancer with ILD; however, it was one of the unfavorable prognostic factors in individuals without ILD28. The gene discussed is MUC1; the disease is lung carcinoma.